Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cihan Ay

Showing results (141-150 of 344) with videos related to

Pageof 35
Sort By:
Journal of Thrombosis and Haemostasis : JTH|May 16, 2025
Bleeding risk and performance of bleeding risk assessment models in patients with venous thromboembolism on anticoagulation: results from the prospective observational bleeding and assess long-term outcomes on health in patients with venous thromboembolism (BACH-VTE) studyTimothy Hoberstorfer, Stephan Nopp, Daniel Steiner, et al.
Atherosclerosis|April 19, 2011
The P-selectin gene Pro715 allele and low levels of soluble P-selectin are associated with reduced P2Y12 adenosine diphosphate receptor reactivity in clopidogrel-treated patientsThomas Gremmel, Christoph W Kopp, Sabine Steiner, et al.
Haematologica|May 26, 2018
Frequency, risk factors, and impact on mortality of arterial thromboembolism in patients with cancerElla Grilz, Oliver Königsbrügge, Florian Posch, et al.
Eclinicalmedicine|September 2, 2025
Arterial and venous thromboembolic events in patients with cancer treated with targeted therapies: a population-based cohort studyFlorian Moik, Erzsébet Horváth-Puhó, Cihan Ay, et al.
Thrombosis and Haemostasis|October 9, 2018
Association of Platelet-to-Lymphocyte Ratio and Neutrophil-to-Lymphocyte Ratio with the Risk of Thromboembolism and Mortality in Patients with CancerElla Grilz, Florian Posch, Oliver Königsbrügge, et al.
Thrombosis Research|April 30, 2013
Response to antiplatelet therapy is independent of endogenous thrombin generation potentialThomas Gremmel, Simon Panzer, Sabine Steiner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2015
Soluble Vascular Endothelial Growth Factor (sVEGF) and the Risk of Venous Thromboembolism in Patients with Cancer: Results from the Vienna Cancer and Thrombosis Study (CATS)Florian Posch, Johannes Thaler, Gerhard-Johann Zlabinger, et al.
Thrombosis Journal|December 1, 2022
Atrial fibrillation and anticoagulation are associated with hospitalisations in patients with end-stage kidney disease on haemodialysis: a prospective population-based cohort studyDaniel Steiner, Sabine Schmaldienst, Matthias Lorenz, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 6, 2022
Growth differentiation factor-15 predicts major bleeding, major adverse cardiac events and mortality in patients with end-stage kidney disease on haemodialysis: findings from the VIVALDI studyStephan Nopp, Oliver Königsbrügge, Sabine Schmaldienst, et al.
Wiener Klinische Wochenschrift|September 20, 2019
Establishing an online physical exercise program for people with hemophiliaBarbara Wagner, Axel Seuser, Steffen Krüger, et al.
Pageof 35

Showing results (141-150 of 344) with videos related to

Sort By:
Pageof 35
Journal of Thrombosis and Haemostasis : JTH|May 16, 2025
Bleeding risk and performance of bleeding risk assessment models in patients with venous thromboembolism on anticoagulation: results from the prospective observational bleeding and assess long-term outcomes on health in patients with venous thromboembolism (BACH-VTE) studyTimothy Hoberstorfer, Stephan Nopp, Daniel Steiner, et al.
Atherosclerosis|April 19, 2011
The P-selectin gene Pro715 allele and low levels of soluble P-selectin are associated with reduced P2Y12 adenosine diphosphate receptor reactivity in clopidogrel-treated patientsThomas Gremmel, Christoph W Kopp, Sabine Steiner, et al.
Haematologica|May 26, 2018
Frequency, risk factors, and impact on mortality of arterial thromboembolism in patients with cancerElla Grilz, Oliver Königsbrügge, Florian Posch, et al.
Eclinicalmedicine|September 2, 2025
Arterial and venous thromboembolic events in patients with cancer treated with targeted therapies: a population-based cohort studyFlorian Moik, Erzsébet Horváth-Puhó, Cihan Ay, et al.
Thrombosis and Haemostasis|October 9, 2018
Association of Platelet-to-Lymphocyte Ratio and Neutrophil-to-Lymphocyte Ratio with the Risk of Thromboembolism and Mortality in Patients with CancerElla Grilz, Florian Posch, Oliver Königsbrügge, et al.
Thrombosis Research|April 30, 2013
Response to antiplatelet therapy is independent of endogenous thrombin generation potentialThomas Gremmel, Simon Panzer, Sabine Steiner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2015
Soluble Vascular Endothelial Growth Factor (sVEGF) and the Risk of Venous Thromboembolism in Patients with Cancer: Results from the Vienna Cancer and Thrombosis Study (CATS)Florian Posch, Johannes Thaler, Gerhard-Johann Zlabinger, et al.
Thrombosis Journal|December 1, 2022
Atrial fibrillation and anticoagulation are associated with hospitalisations in patients with end-stage kidney disease on haemodialysis: a prospective population-based cohort studyDaniel Steiner, Sabine Schmaldienst, Matthias Lorenz, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 6, 2022
Growth differentiation factor-15 predicts major bleeding, major adverse cardiac events and mortality in patients with end-stage kidney disease on haemodialysis: findings from the VIVALDI studyStephan Nopp, Oliver Königsbrügge, Sabine Schmaldienst, et al.
Wiener Klinische Wochenschrift|September 20, 2019
Establishing an online physical exercise program for people with hemophiliaBarbara Wagner, Axel Seuser, Steffen Krüger, et al.
Pageof 35